Glenmark Pharmaceuticals Europe Limited, Fingolimod Glenmark 0.5 mg hard capsules recall
Class 3 medicines recall: The MHRA has published a Class 3 recall for Fingolimod Glenmark 0.5 mg hard capsules.
Published: 21 January 2026
The Medicines and Health products Regulatory Agency (MHRA) has published a Class 3 recall for Fingolimod Glenmark 0.5 mg hard capsules. Glenmark Pharmaceuticals Europe Limited is recalling one batch after stability testing showed out-of-specification results. The batch is being recalled as a precautionary measure following test results that showed a delay in capsule dissolution.
Pharmacists are advised to stop supplying the specific batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Further information, advice and details of the affected batch can be found on the MHRA website.